James Price

Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care

Amelia Payne, Ashley Horne, N. Bayman et al. · Journal of Patient-Reported Outcomes · 2023 · 34 citations · Full text

Pharmacy, Health Informatics, Oncology +16

Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy

N.G. Burnet, T. Mee, Simona Gaito et al. · British Journal of Radiology · 2022 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +7

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

James Price, Hitesh Mistry, Guy Betts et al. · Journal of Clinical Oncology · 2022 · 29 citations · Full text

Medicine, Oncology, Chemotherapy +9

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

David Thomson, Clare Cruickshank, Helen Baines et al. · Clinical and Translational Radiation Oncology · 2022 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

David Thomson, Helen Baines, Guy Betts et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 21 citations · Full text

Medicine, Oncology, Radiation Oncology +16